Laurion Capital Management’s 9 Meters Biopharma NMTR Stock Holding History

Laurion Capital Management’s Portfolio NMTR Stock Details NMTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-218,710	Closed	-$147K	–	731
2023 Q2	$147K	Sell	218,710 -9,200	-4%	-$8.13K	﹤0.01%	499
2023 Q1	$317K	Hold	227,910	–	–	﹤0.01%	364
2022 Q4	$287K	Hold	227,910	–	–	﹤0.01%	372
2022 Q3	$980K	Buy	227,910 +256	+0.1%	+$1.27K	0.01%	372
2022 Q2	$1.19M	Buy	+227,654	New	+$2.15M	0.02%	265

Other funds holding NMTR

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

SIS

Strategic Investment Solutions Orland Park, Illinois $437M AUM 30.41% 1-Year Est. Return

RCM

Requisite Capital Management Dallas, Texas $537M AUM 12.29% 1-Year Est. Return

BCMLT

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

RFA

Laurion Capital Management's NMTR Position: Q3 2023 in Review

Laurion Capital Management sold out of 9 Meters Biopharma (NMTR) in Q3 2023, closing a stake of 218,710 shares — an estimated $147K sold.

Laurion Capital Management first reported a position in NMTR in Q2 2022 and held it in 5 quarters. The position peaked at $1.19M in Q2 2022. 6 funds tracked by Wall St. Rank hold NMTR as of Q3 2023.

Laurion Capital Management reported no remaining 9 Meters Biopharma position as of Q3 2023 after selling out during the quarter.
Laurion Capital Management sold 218,710 9 Meters Biopharma shares in Q3 2023, an estimated $147K.
Laurion Capital Management first reported a position in 9 Meters Biopharma in Q2 2022 and held it in 5 quarters.
Laurion Capital Management's 9 Meters Biopharma position peaked at $1.19M in Q2 2022.
6 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q3 2023.

Based on Laurion Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.